Abdo E, Ismail M, Al Hadidi S, Al-Mrahleh M, Saleh T, Zihlif M
PLoS One. 2025; 20(1):e0311615.
PMID: 39883638
PMC: 11781647.
DOI: 10.1371/journal.pone.0311615.
Kasinski D, Szeliski K, Drewa T, Pokrywczynska M
Ther Adv Med Oncol. 2025; 17():17588359241297529.
PMID: 39850919
PMC: 11755519.
DOI: 10.1177/17588359241297529.
Mohseni A, Salehi F, Rostami S, Hadiloo K, Hashemi M, Baridjavadi Z
Stem Cell Res Ther. 2025; 16(1):6.
PMID: 39773361
PMC: 11708188.
DOI: 10.1186/s13287-024-04125-0.
Huang C, Li J, Xie Z, Hu X, Huang Y
Int J Biol Sci. 2025; 21(1):40-62.
PMID: 39744442
PMC: 11667803.
DOI: 10.7150/ijbs.95763.
Lodha P, Acari A, Rieck J, Hofmann S, Dieterich L
Cancers (Basel). 2024; 16(23).
PMID: 39682225
PMC: 11640020.
DOI: 10.3390/cancers16234039.
Harnessing extracellular vesicle-mediated crosstalk between T cells and cancer cells for therapeutic applications.
Budayr O, Miller B, Nguyen J
J Control Release. 2024; 378:266-280.
PMID: 39657892
PMC: 11830559.
DOI: 10.1016/j.jconrel.2024.12.011.
Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease management.
Hansen S, Unal B, Kuzu O, Saatcioglu F
Theranostics. 2024; 14(18):6913-6934.
PMID: 39629128
PMC: 11610136.
DOI: 10.7150/thno.100555.
Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies.
Ma Y, Zhang X, Liu C, Zhao Y
MedComm (2020). 2024; 5(12):e70009.
PMID: 39611045
PMC: 11604295.
DOI: 10.1002/mco2.70009.
The Impact of Genetic Mutations on the Efficacy of Immunotherapies in Lung Cancer.
Lui K, Cheung K, Ng W, Wang Y, Au D, Cho W
Int J Mol Sci. 2024; 25(22).
PMID: 39596025
PMC: 11594099.
DOI: 10.3390/ijms252211954.
Harnessing Tumor Cell-Derived Exosomes for Immune Rejection Management in Corneal Transplantation.
Yang J, Kang H, Liu Y, Lu S, Wu H, Zhang B
Adv Sci (Weinh). 2024; 12(2):e2409207.
PMID: 39540242
PMC: 11727379.
DOI: 10.1002/advs.202409207.
MAP kinase kinase 1 (MEK1) within extracellular vesicles inhibits tumour growth by promoting anti-tumour immunity.
Searles S, Chen W, Yee J, Lee P, Lee C, Caron C
J Extracell Vesicles. 2024; 13(10):e12515.
PMID: 39330930
PMC: 11428867.
DOI: 10.1002/jev2.12515.
The biological function of extracellular vesicles in prostate cancer and their clinical application as diagnostic and prognostic biomarkers.
Limonta P, Marchesi S, Giannitti G, Casati L, Fontana F
Cancer Metastasis Rev. 2024; 43(4):1611-1627.
PMID: 39316264
PMC: 11554767.
DOI: 10.1007/s10555-024-10210-w.
Intercellular Molecular Transfer Mediated by Extracellular Vesicles in Cancer.
Adnani L, Rak J
Results Probl Cell Differ. 2024; 73:327-352.
PMID: 39242385
DOI: 10.1007/978-3-031-62036-2_14.
The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer.
Wilczak M, Surman M, PRZYBYlO M
Curr Pharm Des. 2024; 30(35):2765-2784.
PMID: 39113303
DOI: 10.2174/0113816128326325240723051625.
Therapeutic potential of extracellular vesicles from diverse sources in cancer treatment.
Lin H, Zhou J, Ding T, Zhu Y, Wang L, Zhong T
Eur J Med Res. 2024; 29(1):350.
PMID: 38943222
PMC: 11212438.
DOI: 10.1186/s40001-024-01937-x.
Hypoxia-Induced Long Noncoding RNA HIF1A-AS2 Regulates Stability of MHC Class I Protein in Head and Neck Cancer.
Liao T, Chen Y, Li Z, Hsiao A, Huang Y, Hao R
Cancer Immunol Res. 2024; 12(10):1468-1484.
PMID: 38920249
PMC: 11443317.
DOI: 10.1158/2326-6066.CIR-23-0622.
Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer.
Smith S, Brewer D, Hurst R, Cooper C
Cancers (Basel). 2024; 16(9).
PMID: 38730670
PMC: 11083542.
DOI: 10.3390/cancers16091717.
Combined OLA1 and CLEC3B Gene Is a Prognostic Signature for Hepatocellular Carcinoma and Impact Tumor Progression.
Chen Z, Zeng L, Chen Z, Xu J, Zhang X, Ying H
Technol Cancer Res Treat. 2024; 23:15330338241241935.
PMID: 38564315
PMC: 11007312.
DOI: 10.1177/15330338241241935.
Extracellular vesicle-mediated communication between CD8 cytotoxic T cells and tumor cells.
Huang Z, Liu X, Guo Q, Zhou Y, Shi L, Cai Q
Front Immunol. 2024; 15:1376962.
PMID: 38562940
PMC: 10982391.
DOI: 10.3389/fimmu.2024.1376962.
Exosome inhibition improves response to first-line therapy in small cell lung cancer.
Irep N, Inci K, Tokgun P, Tokgun O
J Cell Mol Med. 2024; 28(4):e18138.
PMID: 38353469
PMC: 10865916.
DOI: 10.1111/jcmm.18138.